ALX Oncology Holdings, Inc. (ALXO)
2.45
-0.15
(-5.77%)
USD |
NASDAQ |
Feb 20, 16:00
2.465
+0.02
(+0.61%)
After-Hours: 20:00
ALX Oncology Holdings Shareholders Equity (Quarterly) : 44.80M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Coherus Oncology, Inc. | 87.77M |
| Century Therapeutics, Inc. | 176.35M |
| Climb Bio, Inc. | 177.00M |
| PepGen Inc. | 163.14M |
| Fortrea Holdings, Inc. | 580.80M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.72M |
| Total Liabilities (Quarterly) | 37.92M |
| Debt to Equity Ratio | 0.3484 |
| Current Ratio | 2.399 |
| Net Debt Paydown Yield | 0.38% |